TITLE: Maximizing Energy After Traumatic Brain Injury: A Novel Intervention

Similar documents
Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

Approved for public release; distribution unlimited

Award Number: W81XWH

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

Approved for public release; distribution unlimited

TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

AD (Leave blank) TITLE: Brief cognitive behavioral therapy for military populations

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Mission Connect Mild TBI Translational Research Consortium. U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/OND Male Veterans

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

Promote Adjustment during Reintegration following Deployment

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

TITLE: Improving Work Outcomes for Veterans with Traumatic Brain Injury. San Diego, CA 92161

Detection of Prostate Cancer Progression by Serum DNA Integrity

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

AD (Leave blank) TITLE: Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

TITLE: The Role Of Alternative Splicing In Breast Cancer Progression

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

TITLE: Determination of Optimum Vitamin D Nutrition in Young Women. Omaha, NE 68178

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

TITLE: Gulf War Illness Evaluation of an innovative detoxification program

TITLE: Effect of Reminder Telephone Calls on Mammography Compliance in High Risk

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Minneapolis Veterns Medical Center Minneapolis, MN 55417

TITLE: TREATMENT OF ENDOCRINE-RESISTANT BREAST CANCER WITH A SMALL MOLECULE C-MYC INHIBITOR

TITLE: Breast Density Assessment by Dual Energy X-ray Absorptiometry in Women and Girls. Rachel Novotny, Ph.D. Honolulu, HI 96822

TITLE: Effects of Tobacco Smoke (TS) on growth of clear cell renal cell carcinoma (ccrcc)

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland X Approved for public release; distribution unlimited

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Estrogen-DNA Adducts as Novel Biomarkers for Ovarian Cancer Risk and for Use in Prevention

Award Number: W81XWH TITLE: Characterizing an EMT Signature in Breast Cancer. PRINCIPAL INVESTIGATOR: Melanie C.

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

TITLE: Prevention and Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

TITLE: Role of ADAM15 in Tumor/Endothelial Interactions Prostate Cancer Regression

CONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle, WA 98109

TITLE: Interchromosomal Associations that Alter NF1 Gene Expression Can Modify Clinical Manifestations of Neurofibromatosis 1. Palo Alto, CA 94304

CONTRACTING ORGANIZATION: The Trustees of Columbia University in City of New York New York, NY

Award Number: W81XWH TITLE: A Novel Membrane-Permeable, Breast-Targeting, Pro-Apoptotic Peptide for Treatment of Breast Cancer

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Joan & Sanford I. Weill Medical College of Cornell University New York, NY 10065

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine, New York, NY 10029

TITLE: Polychlorinated Biphenyls, Organochlorines & PD Risk: A Case Control Study in Alaska

Award Number: MIPR 3GD3DN3081. TITLE: Outcomes of Telehealth Group Psychosocial Interventions for Breast Cancer Patients and Their Partners

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

TITLE: Inhibitors of Histone Deacetylases for Radiosensitization of Prostate Cancer

Award Number: W81XWH TITLE: Regenerative Stem Cell Therapy for Breast Cancer Bone Metastasis

RECIPIENT: Lankenau Institute for Medical Research, Wynnewood, PA 19096

TITLE: A Tissue Engineering Approach to Study the Progression of Breast Tumor Metastasis in Bone

Award Number: W81XWH TITLE: Dietary Fish Oil in Reducing Bone Metastasis of Breast Cancer

TITLE: Neural Markers and Rehabilitation of Executive Functioning in Veterans with TBI and PTSD

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia

Transcription:

AD Award Number: W81XWH-10-1-0920 TITLE: Maximizing Energy After Traumatic Brain Injury: A Novel Intervention PRINCIPAL INVESTIGATOR: Ketki D. Raina,PhD, OTR/L CONTRACTING ORGANIZATION: University of Pittsburgh Pittsburgh, PA 15213-3320 REPORT DATE: October 2013 TYPE OF REPORT: Annual Report PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: Approved for Public Release; Distribution Unlimited The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE 2. REPORT TYPE October 2013 Annual 4. TITLE AND SUBTITLE Maximizing Energy After Traumatic Brain Injury: A Novel Intervention 3. DATES COVERED 27 Sep 2012 26 Sep 2013 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-10-1-0920 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Ketki D. Raina; Jennifer Morse; Jennifer Shen; Ellen Whyte E-Mail: kraina@pitt.edu 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) University of Pittsburgh, The AND Pittsburgh, ADDRESS(ES) PA 15213 5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER 8. PERFORMING ORGANIZATION REPORT NUMBER 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR S ACRONYM(S) U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT Approved for Public Release; Distribution Unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT Purpose: The purpose of this randomized clinical trial is to test the effect of a fatigue management program (MAX intervention) compared to a control intervention for decreasing the impact and severity of post-traumatic brain injury (TBI) fatigue, increasing participation in everyday life and physical activity, and reducing work disability. Scope: Up to 73% of TBI patients endorse fatigue as their most challenging symptom hindering reintegration into society. The MA intervention will train individuals to better manage their fatigue. Thirty-eight participants will be randomized to MAX Intervention control groups. All participants will receive the appropriate intervention in two 1:1 sessions/week for 8 weeks via the internet. Outcome measures will be collected at baseline, intervention completion, and 4 weeks and 8 weeks after intervention completio Study Progress: The study is currently ongoing. Forty participants have consented to participate in the study. Nineteen participants in the experimental group and 16 participants in the control group have completed the intervention phase of the study. An additional 2 participants in the control group are currently in the intervention phase. Data analysis will be completed once all participants have completed the study protocol. 15. SUBJECT TERMS Traumatic Brain Injury; Fatigue; Self-management 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT a. REPORT U b. ABSTRACT U c. THIS PAGE U UU 7 18. NUMBER OF PAGES 19a. NAME OF RESPONSIBLE PERSON USAMRMC 19b. TELEPHONE NUMBER (include area code)

Table of Contents Page Introduction.......1 Body....1 Key Research Accomplishments... 3 Reportable Outcomes 4 Conclusion 4 References.NA Appendices NA

INTRODUCTION: The proposed project aims to study the effects of an intervention designed to address chronic pathological fatigue in patients with traumatic brain injury (TBI). TBI is the signature injury of the wars in Iraq and Afghanistan, affecting about 10-20% of returning soldiers. Chronic pathological fatigue, one of the most distressing symptoms following TBI, is not associated with injury severity. Indeed, approximately 44% of soldiers diagnosed with TBI report feeling fatigued. Post-TBI fatigue is associated with problems in emotional, social, physical, and cognitive functioning; reduced participation in everyday life; and slower return to active duty and work. Thus, post-tbi fatigue hinders patients reintegration into the community. The aim of this 2-year single-blind randomized clinical trial is to test the effect of the MAX intervention for decreasing the impact and severity of post-tbi fatigue, increasing participation in everyday life and physical activity, and reducing work disability. In the MAX intervention, an occupational therapist (OT) will use web camera technology to teach participants on a one-to-one basis to apply Energy Conservation Strategies to solve their fatigue-related problems. This teaching will be individualized for each participant using the framework inherent within Problem Solving Therapy. We hypothesize that participants randomized to the MAX Intervention will demonstrate significantly lower fatigue impact and severity; greater participation in everyday life and physical activity; and lower work disability at intervention completion and 4 and 8 weeks after intervention completion compared to baseline; compared to participants randomized to the Health Education Intervention. Thity-eight participants will be randomly assigned to MAX Intervention or Health Education groups. All participants will receive the appropriate intervention in two 1:1 sessions/week for 8 weeks via web cameras. Outcome measures will be collected at baseline, intervention completion, and 4 weeks and 8 weeks after intervention completion. BODY: We have been able to accomplish a majority of the goals for year 1 and some goals for year 2 from the approved Statement of Work. Below is a description of the accomplishments for each of the goals: YEAR 1 1. Obtain approval for conduct of research from the University of Pittsburgh Institutional Review Board and the Office of Research Protections at USAMRMC. We have obtained regulatory approval from the University of Pittsburgh Institutional Review Board and from the Office of Research Protections at USAMRMC. Hence, we have obtained all the necessary regulatory approvals for the conduct of this study. 2. Hire the Research Coordinator for the study. Ms. Amanda Baucom has been hired to serve as the research coordinator for the study. 3. Train the Research Coordinator to: (a) conduct all assessments independently and reliably; (b) troubleshoot computer-related problems that arise during the intervention, (c) complete day-to-day administration of the study competently, and (c) manage study data competently. 1

Ms. Amanda Baucom has been trained and is competent in the following: (a) conduct all assessments independently and reliably; (b) troubleshoot computer-related problems that arise during the intervention, (c) complete day-to-day administration of the study competently, and (c) manage study data competently. 4. Train the Occupational Therapist to administer the Maximizing Energy (MAX) intervention competently. The occupational therapist s adherence to intervention will be checked regularly throughout the study. Any protocol drifts will be discussed with the OT. Reasons for deviations from the protocol will be discussed and strategies to avoid deviations in the future will be discussed. We have trained 2 occupational therapists Dr. Denise Chisholm and Dr. MaryLou Leibold to administer the MAX intervention competently. Both Dr. Chisholm and Dr. Leibold have been administering the intervention to the experimental group. Treatment fidelity is being continuously monitored by the PI and Dr. Jennifer Morse. 5. Conduct chart reviews of the University of Pittsburgh Department of Physical Medicine and Rehabilitation Research Registry to identify potential participants. Mail letters to potential participants in waves of 10, until 50 participants have been recruited for the study. We have identified several recruitment strategies for our study. We use a 4 step process to maximize recruitment and ensure that we recruit an heterogeneous population for our study. Step 1: Participants are recruited through the Department of Physical Medicine and Rehabilitation Research Registry. We contact participants through mailings and follow-up the mailings with a phone call. Step 2: Participants are enrolled through clinics within the University of Pittsburgh Department of PM&R, Neurology, Neurosurgery, the University of Pittsburgh Medical Center Rehabilitation Institute (RI) and affiliated clinical services. Step 3: We have placed several copies of the study fliers in waiting rooms of the outpatient clinics, TBI support group venues, etc. Potential participants contact us directly after viewing the advertisement flyer. Step 4: We have also been able to recruit through current and ongoing research being conducted by research staff within the Dept. of PMR, Neurosurgery and The School of Health and Rehabilitation Sciences. If, while completing research related procedures on another project, a potential participant is identified, the research staff member who already has contact with the potential participant will inform the individual of the additional research opportunity. Step 5: We have been very successful in recruiting participants from local area Traumatic Brain Injury support groups. These recruitment strategies have been very successful. We have consented 40 individuals to participate in the study. 6. Recruit participants that meet inclusion/exclusion criteria in the study and administer the intervention as per the research protocol approved by the local Institutional Review Board and Office of Research Protections at USAMRMC. We have been successful with our recruitment strategies. We have consented 40 2

individuals to participate in the study. Nineteen participants in the experimental group and 16 participants in the control group have completed the intervention phase of the study. 7. Collect baseline and follow-up data at the following four time points: Time 1 (baseline), Time 2 (at intervention completion), Time 3 (4 weeks after intervention completion) and Time 4 (4 weeks after booster session completion). We have been able to collected baseline and follow-up data for participants in the study. Thirty participants have completed all study-related assessments. 8. Concurrently develop a database for data entry and verification. The database for data entry has been developed. We have developed policies for verifying data to prevent data entry errors. YEAR 2 We have not been able to accomplish all Year 2 goals related to the study. Hence, we had requested and have received a one-year no-cost extension for the study. Following is our summary of our Year 2 goals: 1. Continue to recruit participants that meet inclusion/exclusion criteria in the study and administer the intervention as per the research protocol approved by the local Institutional Review Board and Office of Research Protections at USAMRMC. We continue to recruit participants for the study and complete all study-related procedures based on the protocol. 2. Continue to collect baseline and follow-up data. We continue to collect baseline and follow-up data as per study protocol. 3. Conduct data analyses to examine the specific aim of the study: (a) to test the effect of the MAX intervention for decreasing the impact and severity of post-tbi fatigue, increasing participation in everyday life and physical activity, and increasing the ability to return to work. We will conduct data analysis as we complete the all data collection for the study. 4. Disseminate the finding of the study through: (a) presentations at military rehabilitation-specific meetings as well as annual scientific meetings; (b) presentations at rehabilitation and occupational therapy annual scientific meetings, and (c) publications submitted to scientific journals. Findings from the study will be disseminated, once data analysis is completed. KEY RESEARCH ACCOMPLISHMENTS: Our key research accomplishments are as follows: Regulatory approvals for the study have been obtained. The research coordinator and occupational therapists who will deliver the interventions for the study have been trained. 3

A collaborative multi-pronged system has been successful in recruiting participants for the study. Participants are successfully completing the study protocol. REPORTABLE OUTCOMES: At this time we do not have reportable outcomes in terms of publications, abstract presentations, etc. CONCLUSION: We have participants currently undergoing research-related procedures. As we complete our recruitment for the study, we will be able to examine the effect of the Maximizing Energy intervention for decreasing the impact and severity of post-tbi fatigue, increasing participation in everyday life and physical activity, and reducing work disability. REFERENCES: None at this time. APPENDICES: None at this time. SUPPORTING DATA: None at this time. 4